Sugi Predict

Sugi Predict / Compounds / SCHEMBL898908

SCHEMBL898908

SCHEMBL898908

CC[Sn](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.48
▸ PSIP1 O75475 1/20 0.35
▸ TSHR P16473 4/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ ATM Q13315 1/20 0.32
▸ KCNN4 O15554 1/20 0.32
▸ CALM1 P0DP23 1/20 0.32
▸ CES2 O00748 1/20 0.31
▸ CES1 P23141 1/20 0.31
▸ LTA4H P09960 1/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ SLC22A2 O15244 1/20 0.31
▸ SLC22A1 O15245 1/20 0.31
▸ SLC22A3 O75751 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ KCNH2 Q12809 1/20 0.30
▸ GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25355509 1.00 TP53 (0.48) TP53PSIP1TSHRLMNAALOX12
Hydrochloric Acid SCHEMBL15529862 0.97 TP53 (0.46) TP53PSIP1TSHRLMNAALOX12
SCHEMBL11300754 0.79 ACHE (0.36) TP53TSHRACHEALDH1A1
SCHEMBL10932716 0.78 TP53 (0.38) TP53PSIP1TSHRLMNAALOX12
SCHEMBL25359877 0.78 TP53 (0.38) TP53PSIP1TSHRLMNAALOX12
SCHEMBL1031778 0.77 TP53 (0.41) TP53PSIP1TSHRLMNAALOX12
SCHEMBL1029950 0.77 TP53 (0.41) TP53PSIP1TSHRLMNAALOX12
SCHEMBL1030696 0.75 CALM1 (0.35) TP53TSHRLMNAALOX12ACHE
SCHEMBL1030650 0.74 LTA4H (0.38) TP53TSHRCES2CES1LTA4H
SCHEMBL11697465 0.72 TP53 (0.33) TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116948201-A Chain siloxane supercritical carbon dioxide thickener and preparation method thereof 西南石油大学 2023-10-27 — — CN claimed
CN-116655457-A Method for preparing resorcinol 万华化学集团股份有限公司 2023-08-29 — — CN claimed
US-12378265-B2 Process for preparing organotin compounds ENTEGRIS, INC. (US) 2025-08-05 — — US disclosed
EP-4284808-A1 PROCESS FOR PREPARING ORGANOTIN COMPOUNDS Entegris, Inc. (US) 2023-12-06 — — EP disclosed
CN-116948201-A Chain siloxane supercritical carbon dioxide thickener and preparation method thereof 西南石油大学 2023-10-27 — — CN disclosed
US-20230295196-A1 PROCESS FOR PREPARING ORGANOTIN COMPOUNDS ENTEGRIS, INC. 2023-09-21 — — US disclosed
CN-116655457-A Method for preparing resorcinol 万华化学集团股份有限公司 2023-08-29 — — CN disclosed
US-11697660-B2 Process for preparing organotin compounds ENTEGRIS, INC. (US) 2023-07-11 — — US disclosed
WO-2022165381-A1 PROCESS FOR PREPARING ORGANOTIN COMPOUNDS ENTEGRIS, INC. (US) 2022-08-04 — — WO disclosed
US-20220242888-A1 PROCESS FOR PREPARING ORGANOTIN COMPOUNDS MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT 2022-08-04 — — US disclosed
EP-3039043-B1 NATURAL RUBBER MODIFIED BY AN AMINO ACID MICHELIN & CIE (FR) 2019-05-08 — — EP disclosed
WO-2007022945-A2 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS VIACATT N.V. (BE) 2007-03-01 — — WO disclosed
EP-1757613-A1 Multicoordinated metal complexes for use in metathesis reactions Viacatt N.V. (BE) 2007-02-28 — — EP disclosed
US-20070043188-A1 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS TELENE S.A.S. (FR) 2007-02-22 — — US disclosed
US-6624116-B1 Co-feeding a volatile Group 8B metal compound and/or a volatile promoter compound with the paraffinic hydrocarbon and oxygen feedstream into the oxidation reactor under ignition or autothermal process conditions DOW GLOBAL TECHNOLOGIES INC. 2003-09-23 — — US disclosed
EP-1114013-B1 ON-LINE SYNTHESIS AND REGENERATION OF A CATALYST USED IN AUTOTHERMAL OXIDATION DOW CHEMICAL CO (US) 2002-11-27 — — EP disclosed
EP-1114013-A1 ON-LINE SYNTHESIS AND REGENERATION OF A CATALYST USED IN AUTOTHERMAL OXIDATION THE DOW CHEMICAL COMPANY (US) 2001-07-11 — — EP disclosed
US-6166283-A On-line synthesis and regenerating of a catalyst used in autothermal oxidation THE DOW CHEMICAL COMPANY (US) 2000-12-26 — — US disclosed
WO-2000014037-A1 ON-LINE SYNTHESIS AND REGENERATION OF A CATALYST USED IN AUTOTHERMAL OXIDATION THE DOW CHEMICAL COMPANY (US) 2000-03-16 — — WO disclosed
US-4547320-A ANTITUMOR AGENTS NEDERLANDSE CENTRALE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK (NL) 1985-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220242888-A1 PROCESS FOR PREPARING ORGANOTIN COMPOUNDS ETV6, TPMT, TTN TP53 3072/4885PSIP1 3342/4885TSHR 1738/4885
US-20230295196-A1 PROCESS FOR PREPARING ORGANOTIN COMPOUNDS ETV6, TPMT, TTN TP53 3072/4885PSIP1 3342/4885TSHR 1738/4885
US-11697660-B2 Process for preparing organotin compounds ETV6, TPMT, TTN TP53 3072/4885PSIP1 3342/4885TSHR 1738/4885
US-12378265-B2 Process for preparing organotin compounds ETV6, TPMT, TTN TP53 3072/4885PSIP1 3342/4885TSHR 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.